Please ensure Javascript is enabled for purposes of website accessibility
Doctors Try CRISPR Gene Editing for Cancer, a 1st in the US
gvw_ap_news
By Associated Press
Published 6 years ago on
November 6, 2019

Share

The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival, doctors reported Wednesday.

“It’s the most complicated genetic, cellular engineering that’s been attempted so far. This is proof that we can safely do gene editing of these cells.” Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia
The doctors were able to take immune system cells from the patients’ blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects.
The treatment deletes three genes that might have been hindering these cells’ ability to attack the disease, and adds a new, fourth feature to help them do the job.
“It’s the most complicated genetic, cellular engineering that’s been attempted so far,” said the study leader, Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia. “This is proof that we can safely do gene editing of these cells.”
After two to three months, one patient’s cancer continued to worsen and another was stable. The third patient was treated too recently to know how she’ll fare. The plan is to treat 15 more patients and assess safety and how well it works.

Chinese Scientists Reportedly Have Tried This for Cancer Patients

“It’s very early, but I’m incredibly encouraged by this,” said one independent expert, Dr. Aaron Gerds, a Cleveland Clinic cancer specialist.

This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Other cell therapies for some blood cancers “have been a huge hit, taking diseases that are uncurable and curing them,” and the gene editing may give a way to improve on those, he said.
Gene editing is a way to permanently change DNA to attack the root causes of a disease. CRISPR is a tool to cut DNA at a specific spot. It’s long been used in the lab and is being tried for other diseases.
This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Chinese scientists reportedly have tried this for cancer patients, but this is the first such study outside that country. It’s so novel that it took more than two years to get approval from U.S. government regulators to try it.
The early results were released by the American Society of Hematology; details will be given at its annual conference in December.

So Far, the Cells Have Survived and Have Been Multiplying as Intended

The study is sponsored by the University of Pennsylvania, the Parker Institute for Cancer Immunotherapy in San Francisco, and a biotech company, Tmunity Therapeutics. Several study leaders and the university have a financial stake in the company and may benefit from patents and licenses on the technology.
Two of the patients have multiple myeloma, a blood cancer, and the third has a sarcoma, cancer that forms in connective or soft tissue. All had failed multiple standard treatments and were out of good options.
Their blood was filtered to remove immune system soldiers called T cells, which were modified in the lab and then returned to the patients through an IV. It’s intended as a one-time treatment. The cells should multiply into an army within the body and act as a living drug.
So far, the cells have survived and have been multiplying as intended, Stadtmauer said.
“This is a brand new therapy” so not it’s not clear how soon any anti-cancer effects will be seen. Following these patients longer, and testing more of them, will tell, he said.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

UP NEXT

Justice Department Reaches Deal to Allow Boeing to Avoid Prosecution Over 737 Max Crashes

Giants Are No Match for the Tigers’ Montero and Greene

40 minutes ago

Fresno Police Arrest 20 for DUI During Enforcement Operation

52 minutes ago

Caitlin Clark Will Miss at Least Two Weeks With Quad Strain

The Indiana Fever will be without star guard Caitlin Clark for at least two weeks as she deals with a strained left quad. The reigning Rooki...

12 minutes ago

Caitlin Clark Against the NY Liberty
12 minutes ago

Caitlin Clark Will Miss at Least Two Weeks With Quad Strain

David Sanchez Montes is Valley Crime Stoppers' Most Wanted Person of the Day for May 27, 2025. (Valley Crimes Stoppers)
26 minutes ago

Valley Crime Stoppers’ Most Wanted Person of the Day: David Sanchez Montes

29 minutes ago

Trump Threatens Action as Clovis Prepares for CIF State Track Championships

40 minutes ago

Giants Are No Match for the Tigers’ Montero and Greene

52 minutes ago

Fresno Police Arrest 20 for DUI During Enforcement Operation

Irish Taoiseach (Prime Minister) Micheal Martin delivers remarks during his visit at U.S. Vice President JD Vance's residence for breakfast, ahead of St. Patrick's Day, in Washington, D.C., U.S., March 12, 2025. (REUTERS/Leah Millis/File Photo)
1 hour ago

Ireland to Press Ahead With Trade Ban on Israeli-Occupied Areas

Ohtani Leadoff Home Run
1 hour ago

Ohtani’s Great May Continues as He Hits Leadoff HR in 2nd Straight Game

Trucks carrying aid are seen at the Kerem Shalom crossing between Israel and Gaza, on its Israeli side, May 27, 2025. The U.S. and Israel-backed Gaza Humanitarian Foundation earlier this week announced it had started delivering aid to Gaza. REUTERS/Shafiek Tassiem
2 hours ago

Palestinians Flock to US-Backed Aid Centers Despite Concern Over Checks

Help continue the work that gets you the news that matters most.

Search

Send this to a friend